SEC Filings

SEC Filings

Filing date	Description	Form	View
Feb 20, 2008	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-08-034536.pdf 0001193125-08-034536.rtf 0001193125-08-034536.xls
Feb 27, 2008	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-08-038928.pdf 0001193125-08-038928.rtf 0001193125-08-038928.xls
Mar 04, 2008	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-08-016037.pdf 0001181431-08-016037.rtf
Mar 04, 2008	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-08-016060.pdf 0001181431-08-016060.rtf
Mar 12, 2008	Securities offered to employees pursuant to employee benefit plans	S-8	View HTML 0001193125-08-053953.pdf 0001193125-08-053953.rtf 0001193125-08-053953.xls
Mar 13, 2008	Annual report which provides a comprehensive overview of the company for the past year	10-K	View HTML 0001193125-08-055244.pdf 0001193125-08-055244.rtf 0001193125-08-055244.xls
Mar 19, 2008	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000950134-08-005017.pdf 0000950134-08-005017.rtf 0000950134-08-005017.xls
Mar 24, 2008	Amendment to a previously filed 4	4/A	View HTML 0001209191-08-019865.pdf 0001209191-08-019865.rtf
Mar 27, 2008	Statement of changes in beneficial ownership of securities	4	View HTML 0001381981-08-000001.pdf 0001381981-08-000001.rtf
Mar 27, 2008	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-08-020459.pdf 0001209191-08-020459.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE